ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RANCHO CORDOVA, Calif., Sept. 6, 2023 /PRNewswire/ — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023, in New York.
Related news for (THMO)
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
- ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento